Bringing The Next-Generation Of Antibiotics
to win the war against resistant bacteria
Omnix Medical is a biopharmaceutical company
Founded in 2015, Omnix Medical is developing an arsenal of novel antibiotic agents for the treatment of infections involving drug-resistant bacteria.
Omnix’s technology can tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
Our exceptional technology offers a first-in-its-class drug
Moving together towards a better future
MOVING TOGETHER TOWARDS A BETTER FUTURE
WE AT OMNIX MEDICAL
ARE ALWAYS LOOKING FOR EXTRAORDINARY PEOPLE TO JOIN OUR TEAM
Omnix Medical is pleased to announce the addition of two new peptide families – OMN50 and OMN70. At Omnix, we are working hard to build
New mechanism of action (MoA) addressing global increase of antimicrobial resistance (AMR) burden and shortage of potent anti-infectives JERUSALEM, Israel, April 12, 2022 — Omnix
Entirely novel therapeutic principle to combat alarming worldwide rise of antimicrobial resistance (AMR) JERUSALEM, Israel, March 16, 2022 — Omnix Medical, a biopharmaceutical company developing